FI853255L - Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin. - Google Patents

Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.

Info

Publication number
FI853255L
FI853255L FI853255A FI853255A FI853255L FI 853255 L FI853255 L FI 853255L FI 853255 A FI853255 A FI 853255A FI 853255 A FI853255 A FI 853255A FI 853255 L FI853255 L FI 853255L
Authority
FI
Finland
Prior art keywords
bensazepine
framstaellning
tetrahydro
chloro
methyl
Prior art date
Application number
FI853255A
Other languages
English (en)
Other versions
FI853255A0 (fi
Inventor
Stanley John Borowski
Thomas Anthony Post
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of FI853255A0 publication Critical patent/FI853255A0/fi
Publication of FI853255L publication Critical patent/FI853255L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
FI853255A 1984-09-05 1985-08-23 Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin. FI853255L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/647,552 US4541954A (en) 1984-09-05 1984-09-05 Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Publications (2)

Publication Number Publication Date
FI853255A0 FI853255A0 (fi) 1985-08-23
FI853255L true FI853255L (fi) 1986-03-06

Family

ID=24597406

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853255A FI853255L (fi) 1984-09-05 1985-08-23 Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.

Country Status (19)

Country Link
US (1) US4541954A (fi)
EP (1) EP0174118A3 (fi)
JP (1) JPS6168469A (fi)
KR (1) KR860002470A (fi)
AU (1) AU581918B2 (fi)
CA (1) CA1244017A (fi)
DK (1) DK379985A (fi)
EG (1) EG17149A (fi)
ES (1) ES8609266A1 (fi)
FI (1) FI853255L (fi)
GR (1) GR852041B (fi)
HU (1) HU194181B (fi)
IL (1) IL76100A0 (fi)
NO (1) NO853255L (fi)
NZ (1) NZ213141A (fi)
PH (1) PH20796A (fi)
PT (1) PT81018B (fi)
ZA (1) ZA856268B (fi)
ZW (1) ZW13385A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993000811A1 (en) * 1991-07-01 1993-01-21 The General Hospital Corporation Invertebrate phenylethanolamine transporter and the use thereof
WO1993011572A1 (fr) * 1991-12-06 1993-06-10 Yuasa Corporation Pile mince et pile mince monolitique
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
SI2332921T1 (sl) * 2003-06-17 2016-06-30 Arena Pharmaceuticals, Inc. 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid
CN1805939B (zh) 2003-06-17 2010-10-13 艾尼纳制药公司 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物
EP1838677B1 (en) 2004-12-21 2009-09-09 Arena Pharmaceuticals, Inc. Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
EP2322162A1 (en) * 2004-12-23 2011-05-18 Arena Pharmaceuticals, Inc. 5HT2C receptor modulator compositions and methods of use
JP5199997B2 (ja) 2006-04-03 2013-05-15 アリーナ ファーマシューティカルズ， インコーポレイテッド ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス
EP2099743B1 (en) * 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) * 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법
CA2808904A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
SG188364A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Salts of lorcaserin with optically active acids
EP2611449A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
EP3485878A1 (en) 2010-09-01 2019-05-22 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-ht2c agonists useful for weight management
RU2674670C1 (ru) 2012-10-09 2018-12-12 Арена Фармасьютикалз, Инк. Способ коррекции массы тела

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US4251660A (en) * 1978-08-10 1981-02-17 Smithkline Corporation Method for preparing tetrahydroisoquinolines
US4200754A (en) * 1979-02-02 1980-04-29 Smithkline Corporation Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline
ZA827887B (en) * 1981-11-27 1983-11-30 Smithkline Beckman Corp Pharmaceutical compositions and method of producing alpha2 antagonism
IE53962B1 (en) * 1981-11-27 1989-04-26 Smithkline Beckman Corp 3-benzazepines as alpha-2 antagonists
EP0080779B1 (en) * 1981-11-27 1986-07-16 Smithkline Beckman Corporation 3-benzazepines as alpha-2 antagonists

Also Published As

Publication number Publication date
EP0174118A3 (en) 1986-12-30
ZW13385A1 (en) 1985-11-20
PT81018B (en) 1987-06-24
CA1244017A (en) 1988-11-01
GR852041B (fi) 1985-12-19
IL76100A0 (en) 1985-12-31
DK379985A (da) 1986-03-06
DK379985D0 (da) 1985-08-21
KR860002470A (ko) 1986-04-26
ES8609266A1 (es) 1986-09-01
EP0174118A2 (en) 1986-03-12
HU194181B (en) 1988-01-28
PT81018A (en) 1985-09-01
HUT38617A (en) 1986-06-30
ZA856268B (en) 1986-07-30
NO853255L (no) 1986-03-06
ES546285A0 (es) 1986-09-01
AU4648185A (en) 1986-03-13
FI853255A0 (fi) 1985-08-23
JPS6168469A (ja) 1986-04-08
US4541954A (en) 1985-09-17
PH20796A (en) 1987-04-14
NZ213141A (en) 1988-07-28
AU581918B2 (en) 1989-03-09
EG17149A (en) 1989-06-30

Similar Documents

Publication Publication Date Title
FI853193L (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
FI853255L (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
FI852765A0 (fi) Foerfarande foer framstaellning av saosom hjaertmedicin anvaendbara 1,6-naftyridin 2(1h)-oner.
FI852616A0 (fi) Foerfarande foer uppvaermning av tjockvaeggiga glasroer, jaemte anordning.
MX21592A (es) 1,3-oxazolidin-2-ona.
FI853837A0 (fi) Foerfarande foer framstaellning av isolerande, poroesa, formade byggelement.
FI853686L (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
FI852899L (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI851520L (fi) Anordning foer sammanpressning av en blaosfolieslang.
FI853585L (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI850604A0 (fi) Anordning foer styckevis tvaermaetning av laongstraeckta foeremaol, foeretraedesvis virkesstycken.
FI843270A (fi) Foerfarande foer industriellt utnyttjande av till en tjocklek av 0,2-0,3 mm skuret traefaner.
FI852372A0 (fi) Foerfarande foer framstaellning av substituerade 1,3-dioxanderivat.
FI902192A0 (fi) Foerfarande foer framstaellning av 1,3-dihydro-4-pyridinyl-2h-imidazol-2-oner.
FI850758A0 (fi) Foerfarande foer framstaellning av 3-metyl-7-fluor-5-nitrobenzotiofen.
FI841632A0 (fi) Foerfarande foer framstaellning av laett instaellbara, haollbara anod- och jaernfoerelseelektrodkomponenter foer katod katodiskt skydd.
FI843391A0 (fi) Foerfarande foer framstaellning av osymmetriska 1,4-dihydropyridin dikarboxylsyraestrar.
FI842639A0 (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
FI902521A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 6,6-etylen-15,16-metylen-3-oxo-17a-pregn-4-en-21,17 -karbolaktoner.
IT8419415A0 (it) Composti 5, 6, 7,8-tetraidroimidazopiridinici.
NO890473D0 (no) Analogifremgangsmaate for fremstilling av 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner.
FI850668A0 (fi) Anordning foer behandling av roekgaser, speciellt avgaser.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SMITHKLINE BECKMAN CORPORATION